• No results found
  • No results found

  • Setting the pace of progress.

    Speed is imperative in the fight against rare diseases. Families need answers. People need treatment. For Translational Genomics Research Institute (TGen) and its Center for Rare Childhood Disorders, the Phoenix-based research and treatment centre, shortening the "diagnostic odyssey" is only the beginning.

    Watch the video

    Speed is imperative in the fight against rare diseases. Families need answers. People need treatment. For Translational Genomics Research Institute (TGen) and its Center for Rare Childhood Disorders, the Phoenix-based research and treatment centre, shortening the "diagnostic odyssey" is only the beginning.

    MCLAREN X DELL TECHNOLOGIES

    Setting the pace of progress.

    • Company: TGen
    • Industry: Genomics Research Institute
    • Headquarters: Phoenix, Arizona

    Speed is imperative in the fight againstrare diseases. Families need answers. People need treatment. For Translational Genomics Research Institute (TGen)and its Center for Rare Childhood Disorders, the Phoenix-based research and treatment centre, shortening the diagnostic odyssey is only the beginning.

    For when life depends on data.

    TGen's precision medicine explorations bring better treatments to more patients. They take discoveries in the lab and translate them into treatment quickly and effectively. To do this requires being able to manipulate massive quantities of data – moving it to where it needs to be, managing it securely and processing it intelligently. How much data? Well, if you were to type it all out, you'd need a stack of paper 92 metres tall. The analytical challenge of working with a data set of that size requires intelligent systems that can incorporate AI and machine learning. By automating baseline data interrogation, humans are free to focus on the finer points of what it all means. TGen's partnership with Dell Technologies to handle all these complexities results in better outcomes for researchers and patients alike.

    Precision medicine. Personalised care.

    What do we do with a piece of code 3 billion letters long? When it comes to rare diseases, we know that no two people are the same. Teams are now deploying technologies and methodologies that can treat the individual needs of each patient. In the case of neuroblastoma, when at one point two out of every three patients passed away from the disease, progress in this regard is imperative. The protocols and therapies that existed were not going to cut it. But for groups like TGen, being able to mine data from cases, coupled with a deep understanding of genomics, helps to create personalised, targeted treatment that's far superior than traditional methods, relying on Dell Technologies to help them find solutions to problems that haven't even been defined yet.

    “Our partnership with Dell Technologies has been a cornerstone to a lot of work that we've done, and has enabled TGen to stay ahead of the pack, and be a leader in precision medicine.”

    JAMES LOWEY, CIO, TGEN

    Mapping one human genome.

    According to Dr Jeffrey Trent, TGen’s president and research director, if you were to type 60 words a minute, eight hours a day, it would take 50 years to record one human genome, creating a stack of paper as high as the Statue of Liberty – and a single misspelling could cause a disease. Dr Trent credits TGen, Dell and EMC for forming an IT infrastructure that now allows scientists and clinicians to receive this critical information faster than ever thought possible.

    See infographic

    Trailblazers

    11: Side Effects Include Disruption

    Duration 29:01

  • For when life depends on data.

    TGen's precision medicine explorations bring better treatments to more patients. They take discoveries in the lab and translate them into treatment quickly and effectively. To do this requires being able to manipulate massive quantities of data — moving it to where it needs to be, managing it securely and processing it intelligently. How much data? Well, if you were to type it all out, you'd need a stack of paper 92 metres tall. The analytical challenge of working with a data set of that size requires intelligent systems that can incorporate AI and machine learning. By automating baseline data interrogation, humans are free to focus on the finer points of what it all means. TGen's partnership with Dell Technologies to handle all these complexities results in better outcomes for researchers and patients alike.

     

    • Organisation:

      TGen

    • Industry:

      Genomics Research Institute

    • Headquarters:

      Phoenix, Arizona
  •  

    Precision medicine. Personalised care.

    What do we do with a piece of code 3 billion letters long? When it comes to rare diseases, we know that no two people are the same. Teams are now deploying technologies and methodologies that can treat the individual needs of each patient. In the case of neuroblastoma, when at one point two out of every three patients passed away from the disease, progress in this regard is imperative. The protocols and therapies that existed were not going to cut it. But for groups like TGen, being able to mine data from cases, coupled with a deep understanding of genomics, helps to create personalised, targeted treatment that's far superior than traditional methods, relying on Dell Technologies to help them find solutions to problems that haven't even been defined yet.

  •  

    Our partnership with Dell Technologies has been a cornerstone to a lot of work that we've done, and has enabled TGen to stay ahead of the pack, and be a leader in precision medicine.”

    JAMES LOWEY, CIO, TGEN

  • Mapping one human genome.

    According to Dr Jeffrey Trent, TGen’s president and research director, if you were to type 60 words a minute, eight hours a day, it would take 50 years to record one human genome, creating a stack of paper as high as the Statue of Liberty — and a single misspelling could cause a disease. Dr Trent credits TGen, Dell and EMC for forming an IT infrastructure that now allows scientists and clinicians to receive this critical information faster than ever thought possible.

    See infographic

  • TRAILBLAZERS

    11: Side Effects Include Disruption

    Duration: 29:01
  • Discover more customer stories
    •  

      Driving innovation further

      From swing analysis to advanced fitting, Callaway capitalises on vast amounts of data to bring out each player's best.

      See the full customer story
    •  

      Driving the next industrial revolution

      See how the Canadian robot-maker is making their fleet of self-driving vehicles smarter with every software release.

      See the full customer story
    •  

      Industry disruption at 760 MPH

      What does the future of fast look like? A lot like nothing you’ve ever seen before. See how BIG Ideas are re-thinking transportation, and using architectural solutions to transform the way we all live.

      See the full customer story
  • Related content
    •  

      Advancing care, advancing hope

      Learn about our pediatric cancer care initiatives — a multiyear, multibillion-dollar commitment that reaches more than 25,000 children annually.

      Learn more
    •  

      Curing storage needs

      TGen utilizes Dell EMC solutions to enhance its IT infrastructure and manage its petabyte-sized sequencing cluster.

      Learn more
Column Control: EDIT THE DIALOG TO CONFIGURE